Back
Chemomab Therapeutics 10K Form
Sell
38
CMMB
Chemomab Therapeutics
Last Price:
0.66
Seasonality Move:
-18.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-13 | 10Q | CMMB/Chemomab Therapeutics Quarterly |
| 2021-03-09 | 10K | CMMB/Chemomab Therapeutics Annual |
| 2020-11-16 | 10Q | CMMB/Chemomab Therapeutics Quarterly |
| 2020-08-14 | 10Q | CMMB/Chemomab Therapeutics Quarterly |
| 2020-05-07 | 10Q | CMMB/Chemomab Therapeutics Quarterly |
| 2020-03-17 | 10K | CMMB/Chemomab Therapeutics Annual |
Receive CMMB News And Ratings
See the #1 stock for the next 7 days that we like better than CMMB
CMMB Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.86 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.94000 |
|---|---|
| Net Income (TTM): | $-33.08M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Chemomab Therapeutics Earnings Forecast
Key Chemomab Therapeutics Financial Ratios
- The Interest Expense is -0.17% of Operating Income.
- Per Share Earnings over the last 10 years have been positive in 5 years.
Chemomab Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CMMB |
| Website: | chemomab.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CMMB Technical Analysis vs Fundamental Analysis
Sell
38
Chemomab Therapeutics (CMMB)
is a Sell
Is Chemomab Therapeutics a Buy or a Sell?
-
Chemomab Therapeutics stock is rated a Sell
The current Chemomab Therapeutics [CMMB] share price is $0.65. The Score for CMMB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.